Table of Content




1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Increasing Cellular Therapy Clinical Trials
3.1.2. Growth Of Regenerative Medicine
3.1.3. High Prevalence Of Chronic Diseases
3.2. Key Restraints
3.2.1. Increasing Skills Gap
3.2.2. High Costs

4. Key Analytics
4.1. Impact Of Covid-19 On Cell Therapy Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Regulatory Framework
4.5. Opportunity Matrix
4.6. Vendor Landscape

5. Market By Cell Type
5.1. Stem Cell
5.1.1. Bone Marrow
5.1.2. Blood
5.1.3. Umbilical Cord-Derived Stem Cell
5.1.4. Adipose-Derived Stem Cell
5.1.5. Others
5.2. Non-Stem Cell

6. Market By Therapy Type
6.1. Autologous
6.2. Allogeneic

7. Market By Therapeutic Application
7.1. Malignancies
7.2. Musculoskeletal Disorders
7.3. Autoimmune Disorders
7.4. Dermatology
7.5. Other Applications

8. Market By End-User
8.1. Hospitals & Clinics
8.2. Academic & Research Institutes

9. Geographical Analysis
9.1. North America
9.1.1. Market Size & Estimates
9.1.2. Key Drivers
9.1.3. Key Challenges
9.1.4. Key Players
9.1.5. Country Analysis
9.1.5.1. United States
9.1.5.2. Canada

10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.1.4. Business Expansions
10.2. Company Profiles
10.2.1. Anterogen Co Ltd
10.2.2. Bristol Myers Squibb Company
10.2.3. Cells For Cells Sa
10.2.4. Gilead Sciences Inc
10.2.5. Jcr Pharmaceuticals Co Ltd
10.2.6. Kolon Tissuegene Inc
10.2.7. Medipost Co Ltd
10.2.8. Mesoblast Limited
10.2.9. Nuvasive Inc
10.2.10. Smith & Nephew Plc
10.2.11. Stemedica Cell Technologies Inc
10.2.12. Vericel Corporation



List of Figures


List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: North America Cell Therapy Market, Growth Potential, By Cell Type, In 2021
Figure 6: North America Cell Therapy Market, By Stem Cell, 2022-2030 (In $ Million)
Figure 7: North America Cell Therapy Market, Growth Potential, By Stem Cell, In 2021
Figure 8: North America Cell Therapy Market, By Bone Marrow, 2022-2030 (In $ Million)
Figure 9: North America Cell Therapy Market, By Blood, 2022-2030 (In $ Million)
Figure 10: North America Cell Therapy Market, By Umbilical Cord-Derived Stem Cell, 2022-2030 (In $ Million)
Figure 11: North America Cell Therapy Market, By Adipose-Derived Stem Cell, 2022-2030 (In $ Million)
Figure 12: North America Cell Therapy Market, By Others, 2022-2030 (In $ Million)
Figure 13: North America Cell Therapy Market, By Non-Stem Cell, 2022-2030 (In $ Million)
Figure 14: North America Cell Therapy Market, Growth Potential, By Therapy Type, In 2021
Figure 15: North America Cell Therapy Market, By Autologous, 2022-2030 (In $ Million)
Figure 16: North America Cell Therapy Market, By Allogeneic, 2022-2030 (In $ Million)
Figure 17: North America Cell Therapy Market, Growth Potential, By Therapeutic Application, In 2021
Figure 18: North America Cell Therapy Market, By Malignancies, 2022-2030 (In $ Million)
Figure 19: North America Cell Therapy Market, By Musculoskeletal Disorders, 2022-2030 (In $ Million)
Figure 20: North America Cell Therapy Market, By Autoimmune Disorders, 2022-2030 (In $ Million)
Figure 21: North America Cell Therapy Market, By Dermatology, 2022-2030 (In $ Million)
Figure 22: North America Cell Therapy Market, By Other Applications, 2022-2030 (In $ Million)
Figure 23: North America Cell Therapy Market, Growth Potential, By End-User, In 2021
Figure 24: North America Cell Therapy Market, By Hospitals & Clinics, 2022-2030 (In $ Million)
Figure 25: North America Cell Therapy Market, By Academic & Research Institutes, 2022-2030 (In $ Million)
Figure 26: North America Cell Therapy Market, Country Outlook, 2021 & 2030 (In %)
Figure 27: United States Cell Therapy Market, 2022-2030 (In $ Million)
Figure 28: Canada Cell Therapy Market, 2022-2030 (In $ Million)

List of Tables


LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CELL THERAPY
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: NORTH AMERICA CELL THERAPY MARKET, BY CELL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: NORTH AMERICA CELL THERAPY MARKET, BY CELL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: NORTH AMERICA CELL THERAPY MARKET, BY STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: NORTH AMERICA CELL THERAPY MARKET, BY STEM CELL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: NORTH AMERICA CELL THERAPY MARKET, BY THERAPY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: NORTH AMERICA CELL THERAPY MARKET, BY THERAPY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: NORTH AMERICA CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: NORTH AMERICA CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: NORTH AMERICA CELL THERAPY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: NORTH AMERICA CELL THERAPY MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: NORTH AMERICA CELL THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: NORTH AMERICA CELL THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: KEY PLAYERS IN NORTH AMERICA CELL THERAPY MARKET
TABLE 16: LIST FDA-APPROVED CELL THERAPY PRODUCTS
TABLE 17: LIST OF MERGERS & ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 20: LIST OF BUSINESS EXPANSIONS